Market Cap 152.11B
Revenue (ttm) 33.77B
Net Income (ttm) 10.24B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 12.36
Profit Margin 30.32%
Debt to Equity Ratio 0.73
Volume 3,670,300
Avg Vol 4,481,952
Day's Range N/A - N/A
Shares Out 2.62B
Stochastic %K 37%
Beta 0.30
Analysts Strong Sell
Price Target $67.05

Company Profile

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa. The company offers vapour products; heated products, which consists of a battery-powered device and a plant-based substance consumable that is heated; modern oral products, such as nicotine pouches; combustibles, including cigarette sticks and other tobacco stick products; traditional oral p...

Industry: Tobacco
Sector: Consumer Defensive
Phone: 44 20 7845 1000
Fax: 44 20 7845 2118
Website: www.bat.com
Address:
Globe House, 4 Temple Place, London, United Kingdom
Marci911
Marci911 May. 9 at 3:08 PM
$CHUC The FDA currently needs Charlie’s more than the other way around in order to survive politically. If CHUC’s management acts wisely now, they can practically dictate the terms for approval and market entry themselves. $BTI $PM $MO
2 · Reply
Marci911
Marci911 May. 9 at 2:50 PM
$CHUC 1. The Time Pressure: Makary Needs "Wins." FDA Chief Makary has his back against the wall. If he wants to keep his job, he must immediately demonstrate to Trump that he is delivering on the "Save Vaping" promise. He cannot wait for new applications to be drafted; he needs ready-made dossiers that he can quickly rubber-stamp. Charlie’s Advantage: CHUC already has over 670 PMTA applications in the system. The agency simply needs to pull them from the stack and process them. $BTI
1 · Reply
Marci911
Marci911 May. 9 at 2:50 PM
$CHUC 2. The Technological Monopoly (Age-Gating): As you rightly point out, other manufacturers often lack age-gating (age verification technology). With its authorization of Glas Inc. on May 5th, the FDA established a new standard: No authorization without child protection technology. Since Charlie’s has already invested millions in this technology (Bluetooth, ID scanning), they are one of the very few players capable of providing the FDA with exactly what it needs right now—namely, a way to appease Trump without completely abandoning the protection of minors. $BTI
0 · Reply
Marci911
Marci911 May. 9 at 2:48 PM
$CHUC 3. Must Charlie’s amend its PMTAs? Typically, the PMTA process is rigid. However, given the politically charged nature of the current situation, two possibilities exist: "Amendment": Charlie’s could supplement its existing applications with a brief technical update (specifically, the details regarding age-gating) rather than resubmitting everything from scratch. FDA Accommodation: Under the Trump administration, it is entirely conceivable that the agency might proactively reach out to companies like Charlie’s and say: "Submit the technical module for age verification to us, and we will grant a provisional approval." $BTI
0 · Reply
Marci911
Marci911 May. 9 at 2:47 PM
$CHUC 4. The FDA’s “Beggar” Role: Indeed, Makary must now deliver results that are politically actionable. An American company like Charlie’s—one that secures jobs and offers a technological solution to the “youth protection problem”—is the perfect showcase candidate for Trump’s agenda. Rather than Charlie’s having to request meetings, the agency could now prioritize the CHUC files under high pressure in order to announce its next major “success story” as quickly as possible. Conclusion: If Makary wants to save his own skin, he needs showcase companies that are ready to step up. Charlie’s is at the very front of the line. This could be the catalyst for the hype we discussed—for if approval suddenly arrives “overnight,” the market will be caught off guard by the sheer speed of it. $BTI
1 · Reply
Marci911
Marci911 May. 8 at 4:31 PM
$CHUC $MO $PM $BTI $KAVL Conclusion for InvestorsThis interference is no longer an isolated incident, but systematic political direction. For companies like Charlie’s Holdings (CHUC), this is extremely positive, as the regulatory resistance of the FDA is being actively broken by the White House. If Trump forces the FDA to "shift gears," the chances of imminent approvals for other firms increase significantly.
0 · Reply
Marci911
Marci911 May. 8 at 4:29 PM
$CHUC $BTI $MO $PM Continuous Pressure on the AgencyReports suggest Trump is not letting up:Demand for Speed: He continues to push Makary to act faster to allow more products and innovations (such as white-label models or new technologies) onto the market.Political Signal: Trump views vaping as a key issue for young voters in the "MAGA" movement and is using his influence to reverse the strict restrictions of the previous administration.
0 · Reply
jorgegb
jorgegb May. 8 at 9:30 AM
$CHUC Thanks @jboii This week’s events in order: Monday: Trump personally pressures FDA Commissioner on flavored vape approvals Tuesday: FDA authorizes first ever fruit-flavored vapes, age-gating as the pathway Wednesday: National Law Review confirms age-gating is a replicable PMTA pathway Thursday: NACS, the convenience store trade association, CHUC’s own retail channel, covers the authorization for c-store buyers nationwide Friday: Reporting reveals Glas waited 5 years for authorization while FDA’s “Fatal Flaw” review was systematically biased against smaller companies, the exact bias the Fifth Circuit is adjudicating right now. CHUC filed 678 PMTAs in 2020. IKE age-gating deal signed January 2026. U.S. manufacturing operational. State PMTA registries sweeping non-compliant products off shelves. Every single development this week points in the same direction. Show your support on the June 4 vote. NYSE American uplist. Long $CHUC $MO $BTI
1 · Reply
jorgegb
jorgegb May. 7 at 7:44 PM
$CHUC Great article @DonutHole, thanks. The Daily Beast revealed $1M+ in lobbying by Swisher International (connected to Susie Wiles’ daughter’s firm) before Trump pressured FDA on flavored vapes. Here’s the irony: Swisher didn’t benefit from Glas’s authorization. Swisher has been fighting the FDA on its own PMTAs for years while trying to diversify into vaping through its E-Alternative Solutions. CHUC has no connection to any of this lobbying. CHUC’s case is built on IKE age-gating technology validated by the FDA on scientific merit, 0% underage activation, component PMTA accepted, explicitly named in FDA’s March 2026 guidance. But I have to speculate: Swisher spent $1M+ lobbying for flavored vape approvals and still has no authorized flavored product. CHUC has 678 PMTAs and the IKE age-gating pathway the FDA just validated. Swisher is private but a JV or licensing deal with CHUC would give them everything they’ve been lobbying for. Thoughts? Long $CHUC $MO $BTI
3 · Reply
jboii
jboii May. 6 at 7:42 PM
1 · Reply
Latest News on BTI
BAT upgraded to Overweight from Underweight at Morgan Stanley

2026-04-24T09:52:18.000Z - 15 days ago

BAT upgraded to Overweight from Underweight at Morgan Stanley


BAT Says Confident Of Delivering Mid-term Algorithm

2026-04-15T14:21:19.000Z - 24 days ago

BAT Says Confident Of Delivering Mid-term Algorithm


British American Tobacco (BTI) Appoints New CFO for 2026

2026-04-09T10:56:07.000Z - 4 weeks ago

British American Tobacco (BTI) Appoints New CFO for 2026


5 No-Brainer Dividend Stocks to Buy Right Now

Wed, 25 Mar 2026 19:05:00 -0400 - 6 weeks ago

5 No-Brainer Dividend Stocks to Buy Right Now


The Smartest Dividend Stocks to Buy With $150 Right Now

Tue, 17 Mar 2026 08:05:00 -0400 - 7 weeks ago

The Smartest Dividend Stocks to Buy With $150 Right Now


Organigram announces C$65.2M BAT private placement investment

2026-02-19T11:27:08.000Z - 2 months ago

Organigram announces C$65.2M BAT private placement investment

OGI


Organigram announces C$65.2M BAT private placement investment

2026-02-19T11:21:44.000Z - 2 months ago

Organigram announces C$65.2M BAT private placement investment

OGI


British American Tobacco Posts Pretax Profit Jump

Feb 12, 2026, 2:43 AM EST - 3 months ago

British American Tobacco Posts Pretax Profit Jump

BTI


British American Tobacco Keeps Luc Jobin as Chair

Feb 10, 2026, 5:02 AM EST - 3 months ago

British American Tobacco Keeps Luc Jobin as Chair

BTI


British American Tobacco p.l.c. Transcript: Trading Update

Dec 9, 2025, 3:30 AM EST - 5 months ago

British American Tobacco p.l.c. Transcript: Trading Update


Organigram appoints James Yamanaka CEO

2025-11-25T12:20:41.000Z - 5 months ago

Organigram appoints James Yamanaka CEO

OGI


Organigram names James Yamanaka as new CEO

2025-11-25T11:05:43.000Z - 5 months ago

Organigram names James Yamanaka as new CEO

OGI


These Reliable Payers Could Deliver a 5% Yield With Minimal Risk

Tue, 18 Nov 2025 04:45:00 -0500 - 6 months ago

These Reliable Payers Could Deliver a 5% Yield With Minimal Risk


BT share price forecast after earnings: is it a buy or sell?

Nov 6, 2025, 4:16 AM EST - 6 months ago

BT share price forecast after earnings: is it a buy or sell?

BTI


BAT pauses plan to launch disposable vape in U.S., Reuters says

2025-10-28T11:01:03.000Z - 6 months ago

BAT pauses plan to launch disposable vape in U.S., Reuters says


5 Best High-Yield Dividend Stocks to Buy Now

Wed, 17 Sep 2025 05:45:00 -0400 - 8 months ago

5 Best High-Yield Dividend Stocks to Buy Now


British American Tobacco p.l.c. Earnings Call Transcript: H1 2025

Jul 31, 2025, 4:30 AM EDT - 10 months ago

British American Tobacco p.l.c. Earnings Call Transcript: H1 2025


Build Your Dividend Dream: 3 High-Yield Stocks to Buy Now

Mon, 14 Jul 2025 05:39:00 -0400 - 10 months ago

Build Your Dividend Dream: 3 High-Yield Stocks to Buy Now


10 Stocks That Pay $100 or More in Dividends

Mon, 23 Jun 2025 05:30:00 -0400 - 11 months ago

10 Stocks That Pay $100 or More in Dividends


British American Tobacco p.l.c. Transcript: Trading Update

Jun 3, 2025, 3:30 AM EDT - 1 year ago

British American Tobacco p.l.c. Transcript: Trading Update


BAT lifts annual sales target as US demand improves

Jun 3, 2025, 2:23 AM EDT - 1 year ago

BAT lifts annual sales target as US demand improves

BTI


Better High-Yield Dividend Stock: Altria or British American Tobacco?

Fri, 30 May 2025 03:14:00 -0400 - 1 year ago

Better High-Yield Dividend Stock: Altria or British American Tobacco?


Want a Sell-Off Safe Haven? Consider British American Tobacco Stock.

Thu, 08 May 2025 06:05:00 -0400 - 1 year ago

Want a Sell-Off Safe Haven? Consider British American Tobacco Stock.


Final Trade: BTI, CRWD, VLO

May 5, 2025, 6:21 PM EDT - 1 year ago

Final Trade: BTI, CRWD, VLO

CRWD BTI VLO


Could Buying British American Tobacco Stock Today Set You Up for Life?

Fri, 02 May 2025 03:05:00 -0400 - 1 year ago

Could Buying British American Tobacco Stock Today Set You Up for Life?


Final Trade: BATS-GB, BA, TSLA, XOM

Mar 20, 2025, 6:21 PM EDT - 1 year ago

Final Trade: BATS-GB, BA, TSLA, XOM

TSLA XOM BA


3 Dividend Stocks for December 2024

Dec 15, 2024, 11:00 AM EST - 1 year ago

3 Dividend Stocks for December 2024

COP CVS


British American Tobacco to launch synthetic nicotine pouches

Oct 16, 2024, 7:14 AM EDT - 1 year ago

British American Tobacco to launch synthetic nicotine pouches


BAT shares climb as first-half results fuel US optimism

Jul 25, 2024, 2:08 AM EDT - 1 year ago

BAT shares climb as first-half results fuel US optimism


British American Tobacco Keeps Outlook

Jun 4, 2024, 5:40 AM EDT - 2 years ago

British American Tobacco Keeps Outlook


Charlotte's Web Reports 2024 First Quarter Financial Results

May 8, 2024, 7:07 AM EDT - 2 years ago

Charlotte's Web Reports 2024 First Quarter Financial Results


Marci911
Marci911 May. 9 at 3:08 PM
$CHUC The FDA currently needs Charlie’s more than the other way around in order to survive politically. If CHUC’s management acts wisely now, they can practically dictate the terms for approval and market entry themselves. $BTI $PM $MO
2 · Reply
Marci911
Marci911 May. 9 at 2:50 PM
$CHUC 1. The Time Pressure: Makary Needs "Wins." FDA Chief Makary has his back against the wall. If he wants to keep his job, he must immediately demonstrate to Trump that he is delivering on the "Save Vaping" promise. He cannot wait for new applications to be drafted; he needs ready-made dossiers that he can quickly rubber-stamp. Charlie’s Advantage: CHUC already has over 670 PMTA applications in the system. The agency simply needs to pull them from the stack and process them. $BTI
1 · Reply
Marci911
Marci911 May. 9 at 2:50 PM
$CHUC 2. The Technological Monopoly (Age-Gating): As you rightly point out, other manufacturers often lack age-gating (age verification technology). With its authorization of Glas Inc. on May 5th, the FDA established a new standard: No authorization without child protection technology. Since Charlie’s has already invested millions in this technology (Bluetooth, ID scanning), they are one of the very few players capable of providing the FDA with exactly what it needs right now—namely, a way to appease Trump without completely abandoning the protection of minors. $BTI
0 · Reply
Marci911
Marci911 May. 9 at 2:48 PM
$CHUC 3. Must Charlie’s amend its PMTAs? Typically, the PMTA process is rigid. However, given the politically charged nature of the current situation, two possibilities exist: "Amendment": Charlie’s could supplement its existing applications with a brief technical update (specifically, the details regarding age-gating) rather than resubmitting everything from scratch. FDA Accommodation: Under the Trump administration, it is entirely conceivable that the agency might proactively reach out to companies like Charlie’s and say: "Submit the technical module for age verification to us, and we will grant a provisional approval." $BTI
0 · Reply
Marci911
Marci911 May. 9 at 2:47 PM
$CHUC 4. The FDA’s “Beggar” Role: Indeed, Makary must now deliver results that are politically actionable. An American company like Charlie’s—one that secures jobs and offers a technological solution to the “youth protection problem”—is the perfect showcase candidate for Trump’s agenda. Rather than Charlie’s having to request meetings, the agency could now prioritize the CHUC files under high pressure in order to announce its next major “success story” as quickly as possible. Conclusion: If Makary wants to save his own skin, he needs showcase companies that are ready to step up. Charlie’s is at the very front of the line. This could be the catalyst for the hype we discussed—for if approval suddenly arrives “overnight,” the market will be caught off guard by the sheer speed of it. $BTI
1 · Reply
Marci911
Marci911 May. 8 at 4:31 PM
$CHUC $MO $PM $BTI $KAVL Conclusion for InvestorsThis interference is no longer an isolated incident, but systematic political direction. For companies like Charlie’s Holdings (CHUC), this is extremely positive, as the regulatory resistance of the FDA is being actively broken by the White House. If Trump forces the FDA to "shift gears," the chances of imminent approvals for other firms increase significantly.
0 · Reply
Marci911
Marci911 May. 8 at 4:29 PM
$CHUC $BTI $MO $PM Continuous Pressure on the AgencyReports suggest Trump is not letting up:Demand for Speed: He continues to push Makary to act faster to allow more products and innovations (such as white-label models or new technologies) onto the market.Political Signal: Trump views vaping as a key issue for young voters in the "MAGA" movement and is using his influence to reverse the strict restrictions of the previous administration.
0 · Reply
jorgegb
jorgegb May. 8 at 9:30 AM
$CHUC Thanks @jboii This week’s events in order: Monday: Trump personally pressures FDA Commissioner on flavored vape approvals Tuesday: FDA authorizes first ever fruit-flavored vapes, age-gating as the pathway Wednesday: National Law Review confirms age-gating is a replicable PMTA pathway Thursday: NACS, the convenience store trade association, CHUC’s own retail channel, covers the authorization for c-store buyers nationwide Friday: Reporting reveals Glas waited 5 years for authorization while FDA’s “Fatal Flaw” review was systematically biased against smaller companies, the exact bias the Fifth Circuit is adjudicating right now. CHUC filed 678 PMTAs in 2020. IKE age-gating deal signed January 2026. U.S. manufacturing operational. State PMTA registries sweeping non-compliant products off shelves. Every single development this week points in the same direction. Show your support on the June 4 vote. NYSE American uplist. Long $CHUC $MO $BTI
1 · Reply
jorgegb
jorgegb May. 7 at 7:44 PM
$CHUC Great article @DonutHole, thanks. The Daily Beast revealed $1M+ in lobbying by Swisher International (connected to Susie Wiles’ daughter’s firm) before Trump pressured FDA on flavored vapes. Here’s the irony: Swisher didn’t benefit from Glas’s authorization. Swisher has been fighting the FDA on its own PMTAs for years while trying to diversify into vaping through its E-Alternative Solutions. CHUC has no connection to any of this lobbying. CHUC’s case is built on IKE age-gating technology validated by the FDA on scientific merit, 0% underage activation, component PMTA accepted, explicitly named in FDA’s March 2026 guidance. But I have to speculate: Swisher spent $1M+ lobbying for flavored vape approvals and still has no authorized flavored product. CHUC has 678 PMTAs and the IKE age-gating pathway the FDA just validated. Swisher is private but a JV or licensing deal with CHUC would give them everything they’ve been lobbying for. Thoughts? Long $CHUC $MO $BTI
3 · Reply
jboii
jboii May. 6 at 7:42 PM
1 · Reply
Marci911
Marci911 May. 6 at 11:18 AM
$CHUC Looking at the valuations of industry giants, it becomes clear in which league Charlie’s Holdings (CHUC) could play if it permanently overcomes the FDA regulatory hurdle. Within the industry, there is a huge discrepancy between CHUC’s current value (approximately $65 million) and the potential that legal market dominance in the flavor sector offers. $MO $PM $BTI
1 · Reply
Marci911
Marci911 May. 6 at 10:22 AM
$CHUC THE BREAKTHROUGH FOR FRUIT FLAVORS $XXII ? 1. Historical Turning Point: The End of the Blanket Flavor Ban On May 5, 2026, the FDA authorized fruit-flavored e-cigarettes (Mango and Blueberry flavors by Glas Inc.) for the first time in U.S. history. This ends the years-long practice of rejecting nearly all applications for non-tobacco flavors. 2. The "Entry Ticket": AI-Powered Age Verification The authorization for Glas Inc. was granted specifically because of their "Device Access Restriction Technology" (DAR). The device can only be activated via a Bluetooth smartphone connection and a biometric age check (facial scan/ID). The CHUC Advantage: Charlie’s entered a partnership with IKE Tech in January 2026 to integrate exactly this AI-driven age verification into their products. Consequently, CHUC already possesses the technology that is now officially recognized as the gold standard for approval. Is Chuc becoming increasingly interesting for $BTI $PM $MO!?
1 · Reply
jorgegb
jorgegb May. 6 at 2:06 AM
$CHUC The Reddit post from r/pennystocks said it perfectly: “The value is a flavor PMTA…and CHUC has 678 of them.” Here’s what most people are missing, IKE Tech is a joint venture of three companies; Ispire $ISPR, Berify, and Chemular. CHUC’s own board member Dr. Ed Carmines is Chief Scientific Officer at Chemular, one of IKE’s three founding partners. He’s not just on the board. He built part of the technology. It’s clear now why he kept buying CHUC stock at $0.28 and $0.29, above today’s price. Today the FDA authorized the first ever non-tobacco, non-menthol flavored vapes, using age-gating technology as the pathway. The exact technology CHUC licensed from IKE in January 2026. Age-gating devices without PMTAs are worthless. PMTAs without age-gating can’t get flavored approval. CHUC has both. (678 PMTAs + IKE deal signed). And every one of those 678 PMTAs can be amended to incorporate IKE age-gating. Now, we just wait for the NYSE American uplist. Long $CHUC $ISPR $MO $BTI
1 · Reply
AStrokeOfLuck
AStrokeOfLuck May. 6 at 12:07 AM
0 · Reply
jboii
jboii May. 5 at 6:36 PM
$CHUC $BTI $ISPR $MO https://www.reuters.com/legal/litigation/trump-pressures-fdas-makary-approve-flavored-vapes-wsj-reports-2026-05-05/
0 · Reply
jorgegb
jorgegb May. 5 at 6:29 PM
$CHUC Awesome news @DonutHole Here’s another article from the WSJ: https://www.wsj.com/politics/policy/trump-pressures-fda-commissioner-to-approve-flavored-vapes-9dad81ee?st=Yx5Chz&reflink=article_copyURL_share Summary: Trump personally upbraided FDA Commissioner Makary over the weekend for moving too slowly on flavored vape approvals. Presidential calls from Florida. White House meetings Monday. CHUC’s IKE age-gating system showed 0% underage activation in clinical validation. Connect the dots: — Trump demands faster flavored vape approvals — Makary’s block is specifically about youth access — CHUC has the only clinically validated age-gating solution — FDA’s own March 9 guidance names biometric age-gating as a PMTA review factor — 678 PMTAs filed since 2020 — Fifth Circuit ruling pending on PMTA denial process — June 4 proxy vote. NYSE American uplist. IKE doesn’t just help CHUC. IKE solves the FDA’s problem. Long $CHUC $MO $BTI $MO $PM
0 · Reply
Marci911
Marci911 May. 5 at 6:26 PM
0 · Reply
DonutHole
DonutHole May. 5 at 5:57 PM
$CHUC BREAKING: President Donald Trump is intensifying pressure on Food and Drug Administration Commissioner Marty Makary to reverse current agency policy and authorize flavored nicotine products. According to the Wall Street Journal, citing people familiar with the matter. If flavored vapes are approved, the main tobacco companies most likely to benefit are British American Tobacco (BTI) through R.J. Reynolds $BTI $PM $MO
2 · Reply
AStrokeOfLuck
AStrokeOfLuck May. 5 at 5:52 PM
0 · Reply
DonutHole
DonutHole May. 5 at 5:14 PM
$CHUC BREAKING: The Trump Administration wants faster action from the FDA on flavored vapes. $BTI $MO $PM (WSJ paywall)
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 4 at 9:02 PM
$BTI RSI: 53.35, MACD: 0.0146 Vol: 1.24, MA20: 57.73, MA50: 58.41 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
jorgegb
jorgegb May. 4 at 2:29 AM
$BTI $CHUC $MO This was pointed out to me by another shareholder: The FDA is caught in its own trap. Rejecting responsible PMTA applications while ~6,000 illegal vapes flood the market. Congress is demanding a crackdown. But aggressively removing illegal vapes without authorized alternatives means millions of adult vapers go back to cigarettes making it a public health disaster. The only logical escape is accelerating PMTA approvals for responsible manufacturers. Now add this: the current administration just hired a former British American Tobacco vaping executive as CDC Deputy Director for Legislative Affairs. The administration is clearly taking a more favorable stance on vaping. CHUC has 678 PMTAs filed and IKE age-gating answers the FDA’s youth access objection. The Fifth Circuit heard arguments this past week on whether the entire PMTA denial process was unlawful. The FDA needs a solution. CHUC is it. Long $CHUC $MO $BTI
0 · Reply